...
首页> 外文期刊>Endoscopy International Open >Use of over-the-scope-clip (OTSC) improves outcomes of high-risk adverse outcome (HR-AO) non-variceal upper gastrointestinal bleeding (NVUGIB)
【24h】

Use of over-the-scope-clip (OTSC) improves outcomes of high-risk adverse outcome (HR-AO) non-variceal upper gastrointestinal bleeding (NVUGIB)

机译:使用广角夹子(OTSC)可改善高风险不良后果(HR-AO)非静脉曲张上消化道出血(NVUGIB)的结果

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background and study aims Endoscopic treatment of non-variceal upper gastrointestinal bleeding (NVUGIB) with high-risk adverse outcome (HR-AO) features has a high risk of failure. We studied the safety and efficacy of over-the-scope clips (OTSC) to treat these lesions. Patients and methods We included patients who were treated using OTSC for NVUGIB from January 2015 to October 2017. We studied rebleeding and mortality rates and used the Rockall data and our institution’s prior data for comparison. We used descriptive and chi-square statistics. Results We studied 18 patients with 19 bleeding lesions: 9 (47?%) duodenal ulcers, 4 (21?%) Dieulafoy’s lesion, 3 (16?%) gastric ulcer, and 3 (16?%) bleeding after gastric biopsy, gastric polypectomy and endoscopic ultrasound-guided fine-needle aspiration of peri-gastric mass. We applied OTSC as the first-line treatment in 10 (53?%) and as the second-line treatment in 9 (47?%) bleeding lesions. Continued bleeding after OTSC occurred in six patients, but we treated it successfully and achieved complete hemostasis in all patients. We found OTSC use significantly decreased (0?% vs. 53?%, P Conclusion Use of OTSC is safe, efficacious and appears superior to standard treatment for HR-AO NVUGIB. OTSC should be considered as first-line treatment for HR-AO bleeding.
机译:背景和研究目的内镜治疗具有高危不良后果(HR-AO)特征的非静脉曲张上消化道出血(NVUGIB)具有很高的失败风险。我们研究了超视距夹子(OTSC)治疗这些病变的安全性和有效性。患者和方法我们纳入了2015年1月至2017年10月使用OTSC进行NVUGIB治疗的患者。我们研究了再出血和死亡率,并使用了Rockall数据和我们机构的先前数据进行比较。我们使用了描述性和卡方统计。结果我们研究了18例有19个出血性病变的患者:9个(47%)十二指肠溃疡,4个(21 %%)Dieulafoy病灶,3个(16 %%)胃溃疡和3个(16 %%)胃活检,胃癌术后出血息肉切除术和内镜超声引导下胃周肿物的细针抽吸术。我们将OTSC作为一线治疗的10例(53%),作为二线治疗的9例(47%)的出血灶。 OTSC患者中有6例持续出血,但我们成功治疗了所有患者,并实现了完全止血。我们发现OTSC的使用显着减少(0%vs. 53%,P)结论OTSC的使用安全,有效并且优于HR-AO NVUGIB的标准治疗。OTSC应该被视为HR-AO的一线治疗流血的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号